ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Top Stocks Set to Outperform
Over the Next 1 to 3 Months.
Click for your free picks >>

Quote:

Search for Ticker

Free Membership

Search:

CYNO: Cynosure Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

CYNOSURE INC (NASD)
CYNO	10.38	0.22	(2.17%)	Vol. 11,665	16:00 ET

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions and temporarily reduce the appearance of cellulite. Cynosure's products incorporate a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag and diode lasers, as well as intense pulsed light.

General Information

CYNOSURE INC-A

5 Carlisle Road Westford,, MA 01886 Phone: 978 256-4200 Fax: 978-256-6556 Web: www.cynosurelaser.com Email: info@cynosurelaser.com

Industry	LASERS-SYS/COMP
Sector:	Computer and Technology

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/09/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	10.16
52 Week High	12.62
52 Week Low	4.50
Beta	2.01
20 Day Moving Average	54,605.70
Target Price Consensus	13.1

% Price Change
4 Week	-12.52
12 Week	-10.97
YTD	10.19

% Price Change Relative to S&P 500
4 Week	-13.47
12 Week	-16.07
YTD	-8.81

Share Information
Shares Outstanding (millions)	9.77
Market Capitalization (millions)	98.31
Short Ratio	3.77
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	-0.11
Current Year EPS Consensus Estimate	-0.76
Estimated Long-Term EPS Growth Rate	-
Next EPS Report Date	02/09/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.00
30 Days Ago	1.88
60 Days Ago	2.00
90 Days Ago	2.00

Fundamental Ratios

P/E
Current FY Estimate:	-
Trailing 12 Months:	-
PEG Ratio	-

EPS Growth
vs. Previous Year	-140.54%
vs. Previous Quarter	16.67%

Sales Growth
vs. Previous Year	-53.06%
vs. Previous Quarter:	-13.82%

Price Ratios
Price/Book	0.71
Price/Cash Flow	6.13
Price / Sales	1.24

ROE
09/30/09	-7.78
06/30/09	-2.97
03/31/09	2.07

ROA
09/30/09	-6.56
06/30/09	-2.45
03/31/09	1.67

Current Ratio
09/30/09	7.09
06/30/09	6.54
03/31/09	5.60

Quick Ratio
09/30/09	5.83
06/30/09	5.35
03/31/09	4.33

Operating Margin
09/30/09	-13.60
06/30/09	-4.16
03/31/09	2.43

Net Margin
09/30/09	-22.79
06/30/09	-10.16
03/31/09	0.68

Pre-Tax Margin
09/30/09	-22.79
06/30/09	-10.16
03/31/09	0.68

Book Value
09/30/09	14.07
06/30/09	14.09
03/31/09	14.06

Inventory Turnover
09/30/09	1.14
06/30/09	1.34
03/31/09	1.52

Debt-to-Equity
09/30/09	0.00
06/30/09	0.00
03/31/09	0.00

Debt to Capital
09/30/09	0.17
06/30/09	0.20
03/31/09	0.25


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research